Abstract:BACKGROUND: Mutations in SLC26A4, which encodes pendrin, are a common cause of deafness. SLC26A4 mutations are responsible for Pendred syndrome and non-syndromic enlarged vestibular aqueduct (EVA). The mutation spectrum of SLC26A4 varies widely among ethnic groups. To investigate the incidence of EVA in Chinese population and to provide appropriate genetic testing and counseling to patients with SLC26A4 variants, we conducted a large-scale molecular epidemiological survey of SLC26A4.METHODS: A total of 2352 unrelated non-syndromic hearing loss patients from 27 different regions of China were included. Hot spot regions of SLC26A4, exons 8, 10 and 19 were sequenced. For patients with one allelic variant in the hot spot regions, the other exons were sequenced one by one until two mutant alleles had been identified. Patients with SLC26A4 variants were then examined by temporal bone computed tomography scan for radiological diagnosis of EVA. Ten SLC26A4 variants were cloned for functional study. Confocal microscopy and radioisotope techniques were used to examine the membrane expression of pendrin and transporter function.RESULTS: Of the 86 types of variants found, 47 have never been reported. The ratio of EVA in the Chinese deaf population was at least 11%, and that in patients of Han ethnicity reached at least 13%. The mutational spectrum and mutation detection rate of SLC26A4 are distinct among both ethnicities and regions of Mainland China. Most of the variants caused retention of pendrin in the intracellular region. All the mutant pendrins showed significantly reduced transport capability.CONCLUSION: An overall description of the molecular epidemiological findings of SLC26A4 in China is provided. The functional assessment procedure can be applied to identification of pathogenicity of variants. These findings are valuable for genetic diagnosis, genetic counseling, prenatal testing and pre-implantation diagnosis in EVA families.

Identification of a Novel Mutation of SLC26A4 Gene with Enlarged Vestibular Aqueduct Syndrome

Compound heterozygous mutations of SLC26A4 in 4 Chinese families with enlarged vestibular aqueduct.

Identification of two novel mutations, c.232T>C and c.2006A>T, in SLC26A4 in a Chinese family associated with enlarged vestibular aqueduct

Identification of a Novel Mutation in SLC26A4 Gene in a Chinese Family with Enlarged Vestibular Aqueduct Syndrome.

A Distinct Spectrum of SLC26A4 Mutations in Patients with Enlarged Vestibular Aqueduct in China

SLC26A4 Mutations in 135 Cases of Hearing Loss Associated with Enlarged Vestibular Aqueduct

Analysis of SLC26A4 gene mutations in 4 families associated with large vestibular aqueduct syndrome

Genetic Testing for the Enlarged Vestibular Aqueduct Syndrome and Mutation Analysis of the SLC26A4 Gene

A Novel Compound Heterozygous Mutation of SLC26A4 in Two Chinese Families with Nonsyndromic Hearing Loss and Enlarged Vestibular Aqueducts

Analysis of SLC26 A4 gene mutations in 5 families associated with enlarge vestibular aqueduct syndrome

Molecular etiology of hearing impairment associated with nonsyndromic enlarged vestibular aqueduct in East China.

Molecular analysis of hearing loss associated with enlarged vestibular aqueduct in the mainland Chinese: a unique SLC26A4 mutation spectrum

The Incidence and Pathogenic Correlation of SLC26A4 Mono-allelic Mutations in Deaf Patients with Enlarged Vestibular Aqueduct

Exonic Deletions and Deep Intronic Variants of the SLC26A4 Gene Contribute to the Genetic Diagnosis of Unsolved Patients With Enlarged Vestibular Aqueduct

Genetic Diagnosis and Cochlear Implantation for Patients with Nonsyndromic Hearing Loss and Enlarged Vestibular Aqueduct

Two Compound Heterozygous Were Identified in SLC26A4 Gene in Two Chinese Families With Enlarged Vestibular Aqueduct

A Pathogenesis Analysis of SLC26A4 Gene Mutations in 3 Families Associated with Large Vestibular Aqueduct Syndrome

Application of DNA Microarray and Sequencing in Genetic Diagnosis of Enlarged Vestibular Aqueduct Syndrome

Molecular Diagnosis of SLC26A4,FOXI1 and KCNJ10 Gene in 35 Shanghai Probands with Non-Syndromic Hearing Loss Associated with Enlarged Vestibular Aqueduct

Molecular Epidemiology and Functional Assessment of Novel Allelic Variants of SLC26A4 in Non-Syndromic Hearing Loss Patients with Enlarged Vestibular Aqueduct in China

Clinical Phenotypic Characterization of the SLC26A4 Mutation in Pendred Syndrome/Nonsyndromic Enlarged Vestibular Aqueduct.